alexa Importance of Cutaneous Vasculitis in Rheumatology
ISSN: 2161-1149

Rheumatology: Current Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Importance of Cutaneous Vasculitis in Rheumatology

Ko-Ron Chen*

Department of Dermatology, Saiseikai Central Hospital, Tokyo, Japan

*Corresponding Author:
Dr. Ko-Ron Chen, MD, PhD
Head of Department of Dermatology
Saiseikai Central Hospital 1-4-17 Mita
Minato-ku, Tokyo 108-0073, Japan
Tel: 81-3-3451-8211
Fax: 81-3-3451-6102
E-mail: [email protected]

Received Date: November 07, 2013; Accepted Date: April 21, 2014; Published Date: April 28, 2014

Citation: Chen KR (2014) Importance of Cutaneous Vasculitis in Rheumatology. Rheumatology (Sunnyvale) 4: 131. doi: 10.4172/2161-1149.1000131

Copyright: © 2014 Chen KR. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Cutaneous vasculitis may present as a significant component of many systemic vasculitic syndromes such as rheumatoid vasculitis or anti-neutrophil cytoplasmic antibody (ANCA) associated primary vasculitic syndromes like microscopic polyangiits. Cutaneous vasculitis manifested most often as palpable purpura or infiltrated erythema indicating dermal small vessel vasculitis and less commonly as nodular erythema, livedo reticularis, deep ulcers or digital gangrene suggesting subcutaneous muscular vessel vasculitis.Coexistence of dermal small vessel vasculitis and subcutaneous muscular vessel vasculitis usually indicated systemic vasculitis such as connective tissue disease (CTD)-associated vasculitis, ANCA associated vasculitis. Behcet’s disease, polyarteiritsnodosa, Cogan’s syndrome, and malignancy associated. An appropriate lesional skin biopsy is the key to obtaining the diagnosis. Treatment for cutaneous vasculitis should include devoid of the triggers (excessive standing, infection, drugs) and exclusion of vasculitis-like syndromes (psudovasculitis). In most instances, cutaneous vasculitis represents a self-limited condition and will be relieved by leg elevation, avoidance of standing and therapy with non-steroidal antiinflammatory drugs.For mild recurrent or persistent disease, colchicine and daps one are first-choice agents. Severe cutaneous and systemic disease requires more potent immunosuppression (prednisone plus azathioprine, methotrexate, cyclophosphamide).The new biologic therapies that work via cytokine blockade or lymphocyte depletion such as tissue necrosis factor-inhibitor infliximab and the anti-B cell antibody rituximab, respectively, are showing benefit in certain settings such as CTD and ANCA associated vasculitis. Rheumatologists who are familiar with the complicated clinical and histopathological spectrum of cutaneous vasculitis and correlation of systemic vasculitis as well as the technique of skin biopsy will make the diagnosis earlier in vasculitis syndromes with skin involvement.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords